A.R.T. Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

A.R.T. Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-29,336	Closed	-$365K	–	1871
2019 Q2	$365K	Buy	+29,336	New	+$390K	0.02%	874
2017 Q1	–	Sell	-12,100	Closed	-$182K	–	1835
2016 Q4	$182K	Buy	+12,100	New	+$160K	0.01%	1082
2016 Q2	–	Sell	-76,558	Closed	-$707K	–	1752
2016 Q1	$707K	Buy	76,558 +23,500	+44%	+$253K	0.03%	726
2015 Q4	$787K	Sell	53,058 -98,304	-65%	-$1.64M	0.04%	674
2015 Q3	$2.48M	Buy	151,362 +95,146	+169%	+$1.95M	0.09%	308
2015 Q2	$1.28M	Buy	+56,216	New	+$1.12M	0.04%	627
2015 Q1	–	Sell	-32,412	Closed	-$390K	–	1804
2014 Q4	$390K	Sell	32,412 -4,593	-12%	-$52.5K	0.01%	1004
2014 Q3	$419K	Sell	37,005 -48,046	-56%	-$548K	0.02%	819
2014 Q2	$1.03M	Sell	85,051 -1,743	-2%	-$20.6K	0.05%	499
2014 Q1	$1.01M	Buy	86,794 +38,001	+78%	+$644K	0.05%	494
2013 Q4	$862K	Buy	48,793 +30,680	+169%	+$516K	0.05%	534
2013 Q3	$260K	Buy	18,113 +1,930	+12%	+$29.5K	0.01%	1030
2013 Q2	$243K	Buy	+16,183	New	+$214K	0.01%	1110

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

A.R.T. Advisors's MNTA Position: Q3 2019 in Review

A.R.T. Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2019, closing a stake of 29,336 shares — an estimated $365K sold.

A.R.T. Advisors first reported a position in MNTA in Q2 2013 and held it in 13 quarters. The position peaked at $2.48M in Q3 2015. 154 funds tracked by Wall St. Rank hold MNTA as of Q3 2019.

A.R.T. Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 29,336 Momenta Pharmaceuticals, Inc. shares in Q3 2019, an estimated $365K.
A.R.T. Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
A.R.T. Advisors's Momenta Pharmaceuticals, Inc. position peaked at $2.48M in Q3 2015.
154 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.